195
Views
6
CrossRef citations to date
0
Altmetric
Hepatobiliary

Propranolol treatment of portal hypertension in cirrhosis patients is better the higher the untreated pressure: a single-centre prospective experience

, , , , &
Pages 969-973 | Received 20 Mar 2013, Accepted 11 May 2013, Published online: 11 Jun 2013

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Morten Daniel Jensen, Hugh Watson, Hendrik Vilstrup & Peter Jepsen. (2023) Non-Selective Beta-Blockers and Risk of Sepsis in Patients with Cirrhosis and Ascites: Results from a Large Observational Study. Clinical Epidemiology 15, pages 775-783.
Read now

Articles from other publishers (5)

Naaventhan Palaniyappan & Jonathan A. Fallowfield. 2022. Portal Hypertension VII. Portal Hypertension VII 135 151 .
Feng Zhang, Hui Xu, Min Chen, Ming Zhang, Jiangqiang Xiao, Yi Wang, Qibin He, Wei Zhang, Xiaochun Yin, Xiaoping Zou & Yuzheng Zhuge. (2019) Dose-dependent effect of propranolol on the hemodynamic response in cirrhotic patients with gastroesophageal varices. European Journal of Gastroenterology & Hepatology 31:3, pages 368-374.
Crossref
Michael Sørensen, Lars P. Larsen, Gerda E. Villadsen, Niels K. Aagaard, Henning Grønbæk, Susanne Keiding & Hendrik Vilstrup. (2018) β-Blockers Improve Presinusoidal Portal Hypertension. Digestive Diseases and Sciences 63:11, pages 3153-3157.
Crossref
Feng Zhang, Xuhong Duan, Ming Zhang, Zhenlei Li, Qibin He, Yi Wang, Chengcheng Miao, Wenqi Zhong, Xiaoping Zou & Yuzheng Zhuge. (2016) Influence of CYP2D6 and β2-adrenergic receptor gene polymorphisms on the hemodynamic response to propranolol in Chinese Han patients with cirrhosis. Journal of Gastroenterology and Hepatology 31:4, pages 829-834.
Crossref
Alberto Ferrarese, Alberto Zanetto, Giacomo Germani, Patrizia Burra & Marco Senzolo. (2016) Rethinking the role of non-selective beta blockers in patients with cirrhosis and portal hypertension. World Journal of Hepatology 8:24, pages 1012.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.